Previous close | 0.5000 |
Open | 0.5000 |
Bid | 0.0000 |
Ask | 0.4500 |
Strike | 7.50 |
Expiry date | 2024-07-19 |
Day's range | 0.5000 - 0.5000 |
Contract range | N/A |
Volume | |
Open interest | 589 |
Here, we discuss some reasons why buying Bioventus (BVS) stock now may turn out to be a prudent move.
J&J (JNJ) seeks expanded use of its HIV-1 therapy, Prezcobix, for younger kids in the United States and Europe.
Biogen's (BIIB) Qalsody is the first therapy approved to treat a rare genetic form of ALS in Europe